HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LQDA
Liquidia Corp
Healthcare Drug Manufacturers - Specialty & Generic · North Carolina, USA · Reports in usd
Market Cap: $6.32B
Market Cap
$6.32B
Enterprise Val
$6.21B
P/E Ratio
45.58
P/B Ratio
32.38
Trailing PEG (1Y)
-0.17
As Of
Aug 19, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$195.1M
Gross Margin93.27%
Profit Margin93.27%
Return on Equity149.64%
Return on Assets36.30%
Current Ratio2.31
Debt/Equity0.94
LT Debt/Equity0.66
Revenue Per Share1.93

Income Statement

Jun 30, 2026
Revenue$171.7M
Cost of Revenue$11.6M
Gross Profit$160.1M
R&D$17.2M
SG&A$57.4M
Operating Expenses$74.6M
Operating Income$85.5M
Interest Expense$6.3M
Tax Expense$7.0M
Net Income$74.7M
EPS (Basic)$0.84
EPS (Diluted)$0.74
EBIT$88.0M
EBITDA$88.7M
Consolidated Income$74.7M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$287.7M
Accounts Receivable$108.6M
Inventory$36.2M
Current Assets$437.7M
LT Investments$0.00
Property, Plant & Equipment$38.6M
Intangibles$6.7M
Non-Current Assets$84.2M
Total Assets$521.9M
Accounts Payable$12.7M
Current Debt$54.9M
Current Liabilities$189.3M
LT Debt$128.0M
Non-Current Liabilities$137.5M
Total Liabilities$326.8M
Total Debt$182.9M
Retained Earnings-$498.7M
Shareholder Equity$195.1M
Shares Outstanding88,928,099

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$80.2M
Investing Cash Flow-$12.2M
Financing Cash Flow-$6.6M
CapEx-$11.2M
Free Cash Flow$69.0M
Depreciation & Amort.$693.0K
Stock-Based Comp$10.4M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$8.1M
Equity Issued/Repaid$1.4M
Dividends Paid$0.00
Net Change in Cash$61.4M
Data cached · Meta live · Daily live · Statements live · TTL 24h